Factors associated with dose escalation of fesoterodine for treatment of overactive bladder in people > 65 years of age: A post hoc analysis of data from the SOFIA study
Neurourology and Urodynamics, EarlyView.
Source: Neurourology and Urodynamics - Category: Urology & Nephrology Source Type: research
More News: Brain | Neurology | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology